Glucocorticoid and mineralocorticoid production in hormonally silent adrenocortical tumor tissue in dogs

Publication date

2026-01

Authors

van Bokhorst, Kirsten LISNI 0000000527808912
van den Berg, Marit F.ORCID 0000-0002-2016-119XISNI 0000000512624635
Kooistra, Hans S.ISNI 0000000394691609
van Wolferen, M EISNI 000000039156716X
Timmermans-Sprang, ElpetraISNI 0000000492958370
Corsini, Andrea
Golinelli, StefaniaISNI 0000000523483532
Bechmann, Nicole
Peitzsch, Mirko
Galac, SaraORCID 0000-0002-4831-4995ISNI 0000000393573977

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

BACKGROUND: No consensus exists regarding the monitoring and therapeutic approach to adrenal tumors (ATs) discovered incidentally by diagnostic imaging, when standard endocrine testing yields negative results. HYPOTHESIS/OBJECTIVES: To evaluate tissue concentrations of adrenocortical steroids in hormonally silent adrenocortical tumors (SATs) in dogs. ANIMALS: Fourteen dogs with SATs (12 unilateral, 2 bilateral), 11 dogs with cortisol-secreting adrenocortical tumors (cs-ACTs) and 10 healthy dogs. METHODS: Observational study. Diagnosis of SAT was based on finding an AT on diagnostic imaging, negative endocrine function tests, and histopathological and immunohistochemical confirmation. Adrenocortical steroid tissue concentrations were measured by liquid chromatography with tandem mass spectrometry and compared between SATs, cs-ACTs, and normal adrenals (NAs). RESULTS: Hormonally silent adrenocortical tumors exhibited higher median tissue cortisol (3.62 ng/mg, range 0.05-18.1) and 21-deoxycortisol (0.08 ng/mg, range 0.00-0.44) concentrations than NAs (cortisol 0.38 ng/mg, range 0.01-1.90; 21-deoxycortisol 0.01 ng/mg, range 0.00-0.03; P = .04 and P = .001, respectively), and these concentrations were not significantly different between SATs and cs-ACTs. Furthermore, SATs' median tissue concentrations of mineralocorticoid precursors corticosterone (2.15 ng/mg, range 0.01-14.1) and 18-OH-corticosterone (0.70 ng/mg, range 0.00-4.89) were higher than in NAs (respectively 0.19 ng/mg [range 0.14-0.54] and 0.05 ng/mg [range 0.01-0.33]; both P = .01) and not different when compared to cs-ACTs. CONCLUSIONS AND CLINICAL IMPORTANCE: This study on tissue metabolomics in ATs in dogs demonstrates comparable tissue concentrations of specific glucocorticoids and mineralocorticoids in SATs and cs-ACTs. This implies that some SATs are not hormonally silent, prompting further studies on diagnostics, treatment, and monitoring recommendations.

Keywords

Cushing’s, adrenal incidentaloma, canine, hyperadrenocorticism, General Veterinary

Citation

van Bokhorst, K L, van den Berg, M F, Kooistra, H S, van Wolferen, M E, Timmermans-Sprang, E P M, Corsini, A, Golinelli, S, Bechmann, N, Peitzsch, M & Galac, S 2026, 'Glucocorticoid and mineralocorticoid production in hormonally silent adrenocortical tumor tissue in dogs', Journal of Veterinary Internal Medicine, vol. 40, no. 1, aalaf087. https://doi.org/10.1093/jvimsj/aalaf087